Skip to main content
Caplight Logo









Ovira

Ovira

Private
MelbourneHealthcare & Life Scienceshttps://ovira.com/

Last Round

Seed

Mar 12, 2020

Total Funding Raised

$1.01M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ovira is a medical technology company that develops non-invasive, wearable devices for menstrual pain relief.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, E-commerce, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

TENS unittranscutaneous electrical nerve stimulationperiod pain reliefmenstrual pain reliefwearable pain deviceperiod cramp reliefdrug-free pain reliefpelvic pain managementDTC healthfemtechendometriosis reliefmedical wearablehealth IoTpain management device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ovira Comparables

Compare Ovira with similar companies based on industry and business-model similarity.

Ovira comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iPulse Medical
93%
Myoovi
90%
Juno Technologies
89%

Ovira Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 12, 2020
AcceleratorJul 22, 2019

Ovira Investors

Notable investors and investment history

Ovira investors
InvestorRounds
StartmateSeed, Accelerator
Blackbird VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Mar 1, 2026

    Monthly visitors increased 58% MoM.

Ovira Filings

Explore SEC and related filing metadata, where available.

Ovira filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ovira's valuation, stock price, and market status.

Is Ovira a public or private company?

Ovira is a private company.

What is the current stock price of Ovira?

Ovira is a private company with no public stock price. No recent secondary market data is available.

How much is Ovira worth (valuation)?

Valuation information for Ovira is not publicly available.

Can I buy Ovira stock?

Ovira shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ovira's last funding round?

Ovira's most recent funding round was Seed on March 12, 2020.

Who are the main investors in Ovira?

Key investors in Ovira include Blackbird Ventures.

Will Ovira IPO soon?

No public IPO plans have been announced for Ovira.

How can I track Ovira secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ovira's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMelbourne
Employee Range2
Year Founded2018
Last FundingMar 12, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?